Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1031
http://purl.obolibrary.org/obo/NCIT_C1031
|
|---|---|
| Preferred Name | Piritrexim |
| Definitions |
A synthetic antifolate agent with antiparasitic, antipsoriatic and antitumor properties. Piritrexim inhibits the enzyme dihydrofolate reductase enzyme, thereby disrupting folate metabolism and DNA synthesis and cell division. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic antifolate agent with antiparasitic, antipsoriatic and antitumor properties. Piritrexim inhibits the enzyme dihydrofolate reductase enzyme, thereby disrupting folate metabolism and DNA synthesis and cell division. (NCI04) |
|---|---|
| prefLabel | Piritrexim
|
| label | Piritrexim
|
| Has_Salt_Form | |
| PDQ_Closed_Trial_Search_ID | 40070
|
| code | C1031
|
| prefixIRI | NCIT:C1031
|
| in_subset | |
| Preferred_Name | Piritrexim
|
| FDA_UNII_Code | MK2A783ZUT
|
| Contributing_Source | FDA
|
| Chemical_Formula | C17H19N5O2
|
| Maps_To | Piritrexim
|
| CAS_Registry | 72732-56-0
|
| NSC Number | 351521
|
| NCI_Drug_Dictionary_ID | 40070
|
| Legacy Concept Name | Piritrexim
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate antagonists.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40070
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0054332
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |